| __timestamp | Amicus Therapeutics, Inc. | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20717000 | 59644696 |
| Thursday, January 1, 2015 | 47269000 | 79541000 |
| Friday, January 1, 2016 | 71151000 | 98015000 |
| Sunday, January 1, 2017 | 88671000 | 103958000 |
| Monday, January 1, 2018 | 127200000 | 103654000 |
| Tuesday, January 1, 2019 | 169861000 | 128951000 |
| Wednesday, January 1, 2020 | 156407000 | 135799000 |
| Friday, January 1, 2021 | 192710000 | 149883000 |
| Saturday, January 1, 2022 | 213041000 | 220206000 |
| Sunday, January 1, 2023 | 275270000 | 265542000 |
Igniting the spark of knowledge
In the dynamic world of biotechnology, understanding financial trends is crucial for investors and stakeholders. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two prominent biotech companies: Amicus Therapeutics, Inc. and Travere Therapeutics, Inc., from 2014 to 2023.
Amicus Therapeutics has shown a remarkable increase in SG&A expenses, growing by approximately 1,230% over the decade. Starting at $20.7 million in 2014, it reached a peak of $275.3 million in 2023. Travere Therapeutics, on the other hand, experienced a 345% increase, with expenses rising from $59.6 million to $265.5 million in the same period.
This upward trend in SG&A expenses reflects strategic investments in marketing, administration, and sales, crucial for sustaining growth and competitive advantage in the biotech sector.
AbbVie Inc. or Travere Therapeutics, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Merck & Co., Inc. vs Amicus Therapeutics, Inc. Trends and Insights
Amgen Inc. or Amicus Therapeutics, Inc.: Who Manages SG&A Costs Better?
Genmab A/S or Amicus Therapeutics, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Jazz Pharmaceuticals plc and Travere Therapeutics, Inc.
Comparing SG&A Expenses: Grifols, S.A. vs Travere Therapeutics, Inc. Trends and Insights
ADMA Biologics, Inc. and Amicus Therapeutics, Inc.: SG&A Spending Patterns Compared
Perrigo Company plc or Amicus Therapeutics, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Amicus Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated
Who Optimizes SG&A Costs Better? Amicus Therapeutics, Inc. or Wave Life Sciences Ltd.
Operational Costs Compared: SG&A Analysis of Dynavax Technologies Corporation and Travere Therapeutics, Inc.
Taro Pharmaceutical Industries Ltd. or Travere Therapeutics, Inc.: Who Manages SG&A Costs Better?